| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 06/07/2007 | US20070128124 Aerosolized capreomycin for inhibition of pulmonary tuberculosis |
| 06/07/2007 | US20070128123 Stable aqueous solution for aerosol administering |
| 06/07/2007 | US20070128122 Volatile material-containing compositions having an end of service indicator |
| 06/07/2007 | US20070128121 Polymer hydrogels for controlled release and absorption of biocides |
| 06/07/2007 | US20070125269 Highly Oil Absorbing Amorphous Silica Particles |
| 06/07/2007 | CA2632866A1 Noncompetitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2632547A1 Slow-release composition, method for the preparation thereof, and use of the same |
| 06/07/2007 | CA2631757A1 Novel mometasone compositions and methods of making and using the same |
| 06/07/2007 | CA2631755A1 Stable pharmaceutical compositions of 5,10 methylenetetrahydrofolate |
| 06/07/2007 | CA2631677A1 Amphoteric liposome formulation |
| 06/07/2007 | CA2631123A1 Composition in the form of a spray containing a corticoid and an oil phase |
| 06/07/2007 | CA2631054A1 Base material for producing food and fodder |
| 06/07/2007 | CA2630578A1 Orally absorbed pharmaceutical formulation and method of administration |
| 06/07/2007 | CA2629850A1 Competitive domain antibody formats that bind interleukin 1 receptor type 1 |
| 06/07/2007 | CA2629260A1 Inhaler and store for a dry medicament formulation and related methods and use thereof |
| 06/07/2007 | CA2628907A1 Oral pharmaceutical dosage form comprising as active ingredients a proton pump inhibitor together with acetyl salicyclic acid |
| 06/07/2007 | CA2568825A1 Nano-and/or micro-particulate formulations for local injection-based treatment of vascular diseases |
| 06/06/2007 | EP1792985A1 Cell fusion promoter and utilization of the same |
| 06/06/2007 | EP1792983A1 Recombinant alpha-L-iduronidase, methods for producing and purifying the same and methods for treating diseases caused by deficiences thereof |
| 06/06/2007 | EP1792939A1 Blends of gelling and non-gelling starches with gellan gums and plasticizer |
| 06/06/2007 | EP1792927A1 Novel block copolymer, micelle preparation, and anticancer agent containing the same as active ingredient |
| 06/06/2007 | EP1792910A2 Effectors of dipeptidyl peptidase IV for topical use |
| 06/06/2007 | EP1792628A1 Vaccines |
| 06/06/2007 | EP1792624A1 Modified amino acids and compositions comprising them for delivering active agents |
| 06/06/2007 | EP1792621A1 Orally administrable heparin derivatives |
| 06/06/2007 | EP1792616A1 Composition comprising an HMG-CoA inhibitor and a nicotinic acid compound for treating hyperlipidemia |
| 06/06/2007 | EP1792612A2 Transdermal nutritional supplement delivery patch |
| 06/06/2007 | EP1792611A1 Matrix controlled transdermal system for stable derivatives of ACE inhibitors |
| 06/06/2007 | EP1792610A2 Sustained release bioadhesive therapeutic systems |
| 06/06/2007 | EP1791891A1 Substituted organopolysiloxanes and use thereof |
| 06/06/2007 | EP1791643A1 Multi-cap reservoir devices for controlled release or exposure of reservoir contents |
| 06/06/2007 | EP1791553A2 Compositions for delivering peptide yy and pyy agonists |
| 06/06/2007 | EP1791550A2 Use of atp for the manufacture of a medicament for the prevention and treatment of oxidative stress and related conditions |
| 06/06/2007 | EP1791547A1 Oral formulations of paricalcitol |
| 06/06/2007 | EP1791533A2 Transdermal therapeutic system comprising an adhesive layer method for siliconizing the back layer of the system and use of said back layer |
| 06/06/2007 | EP1791532A2 Composition in micro-pellets with controlled release of physiologically active substances, procedure for their preparation and use in the zootechnical sector |
| 06/06/2007 | EP1791531A1 Paroxetine formulations |
| 06/06/2007 | EP1791530A2 Psychostimulant containing pharmaceutical composition |
| 06/06/2007 | EP1791529A2 P277 peptide formulations or variants thereof having optimised stability |
| 06/06/2007 | EP1791528A1 Lyophilisate containing n-diaminomethylene-2-methyl-4,5-di-(methylsulfonyl)-benzamide |
| 06/06/2007 | EP1791527A2 Coating composition |
| 06/06/2007 | EP1791526A2 Pharmaceutical multiparticulate composition comprising mycophenolic acid or mycophenolate sodium and combination compositions with rapamycin |
| 06/06/2007 | EP1791525A1 Liposomal compositions of glucocorticoid and glucocorticoid derivatives |
| 06/06/2007 | EP1791524A2 Pharmaceutical composition comprising a solid dispersion with a polymer matrix containing a continuous polydextrose phase and a continuous phase of a polymer other than polydextrose |
| 06/06/2007 | EP1791523A1 Viscoelastic solution or gel formulation, and methods of treating a body site with the same |
| 06/06/2007 | EP1791522A1 Dermally applicable formulations for treating skin diseases in animals |
| 06/06/2007 | EP1791521A2 Methods of administering water-soluble prodrugs of propofol |
| 06/06/2007 | EP1791520A2 Controlled release nanoparticle active agent formulation dosage forms and methods |
| 06/06/2007 | EP1791519A2 Therapeutic foam |
| 06/06/2007 | EP1791506A2 Methods of device-assisted drug delivery |
| 06/06/2007 | EP1619962B1 Composition for oral administration containing capsaicinoids |
| 06/06/2007 | EP1613297B1 Therapeutic patch with polysiloxane matrix comprising capsaicin |
| 06/06/2007 | EP1558221B1 Dosage form that is safeguarded from abuse |
| 06/06/2007 | EP1542666B1 Modafinil pharmaceutical compositions |
| 06/06/2007 | EP1517683B1 Sustained release tablet containing indapamide |
| 06/06/2007 | EP1406637B1 Pharmaceutical compositions with wound healing or anti-complementary activity comprising a dextran derivative |
| 06/06/2007 | EP1392254B1 Micellar drug delivery systems for hydrophobic drugs |
| 06/06/2007 | EP1363601B1 Amphoteric liposomes and the use thereof |
| 06/06/2007 | EP1335764B1 Device and system for patient infusion |
| 06/06/2007 | EP1333865A4 Inorganic low density radionuclide coated particles |
| 06/06/2007 | EP1284146B1 Liposomes containing hydrophobic iodo compound |
| 06/06/2007 | EP1283699B1 Injectable suspensions having improved injectability properties |
| 06/06/2007 | EP1229922B1 Aplidine treatment of cancers |
| 06/06/2007 | EP1158958B1 Improved powdery pharmaceutical compositions for inhalation |
| 06/06/2007 | EP0839039B2 Paroxetine controlled release compositions |
| 06/06/2007 | DE102005058166A1 Matrixkontrolliertes transdermales System mit Amin-Salzen der ACE-Hemmer-Dicarbonsäuren Controlled matrix transdermal system with amine salts of the ACE inhibitor dicarboxylic acids |
| 06/06/2007 | DE102005057685A1 Inhalator und Speicher für eine trockene Arzneimittelformulierung sowie diesbezügliche Verfahren und Verwendung Inhaler and dry storage for a drug formulation and related procedures and use |
| 06/06/2007 | CN1977025A Azeotrope-like compositions of tetrafluoropropene and hydrofluorocarbons |
| 06/06/2007 | CN1976989A Gel-form water-absorbing material |
| 06/06/2007 | CN1976751A Porous article for delivering chemical substances |
| 06/06/2007 | CN1976748A Granules comprising a beta-lactam antibiotic |
| 06/06/2007 | CN1976712A Medical solution, method for producing and use thereof |
| 06/06/2007 | CN1976711A Administration of cisplatin by inhalation |
| 06/06/2007 | CN1976689A Topical methadone compositions and methods for using the same |
| 06/06/2007 | CN1976688A Pegylated nanoparticles |
| 06/06/2007 | CN1976687A Immune response stimulating composition comprising nanoparticles based on a methyl vinyl ether-maleic acid copolymer |
| 06/06/2007 | CN1976686A Rapidly dispersible, fine-grained, separation-resistant pulverulent film coating agent, based on polyvinyl alcohol-polyether graft copolymers and characterised by a particular physical stability and a |
| 06/06/2007 | CN1976685A Oral antimicrobial pharmceutical compositions |
| 06/06/2007 | CN1976684A Optically controlled microfluidic chip |
| 06/06/2007 | CN1976683A Oral sustained release formulation of tedisamil with gastric retention properties |
| 06/06/2007 | CN1976682A Microparticulate oral galenical form for the delayed and controlled release of pharmaceutical active component |
| 06/06/2007 | CN1976681A Magnetically targetable mitomycin C compositions and methods of their use |
| 06/06/2007 | CN1976680A Injectable microspheres from unsaturated functionalized polyhydric alcohol esters |
| 06/06/2007 | CN1976679A Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid |
| 06/06/2007 | CN1976678A Manufacturing of quick release pharmaceutical compositions of water insoluble drugs and pharmaceutical compositions obtained by the process of the invention |
| 06/06/2007 | CN1976581A Use of ether group-containing polymers as solubilizers |
| 06/06/2007 | CN1974595A Amino butanetriol aescin and its prepn process |
| 06/06/2007 | CN1974557A 5-arylamino quinolyl-7,8-dione derivative and its application in preparing antibiotic medicine |
| 06/06/2007 | CN1973903A Oral vaccine of recombinant gene for preventing Helicobacter pylori infection and its prepn process |
| 06/06/2007 | CN1973901A Composite microsphere prepn of lactic acid-hydroxyacetic acid copolymer and its prepn process |
| 06/06/2007 | CN1973900A Matrix for Chinese medicine plaster and its prepn |
| 06/06/2007 | CN1973897A Quality control method for puerperal blood clot dispersing tablet |
| 06/06/2007 | CN1973893A Externally applied medicine for treating neck and waist arthrosis |
| 06/06/2007 | CN1973892A Addiction eliminating ointment |
| 06/06/2007 | CN1973891A Honey paste for treating women's deficiency |
| 06/06/2007 | CN1973890A Medicine prepn for promoting intelligence growth and nourishing brain and its prepn process |
| 06/06/2007 | CN1973887A Medicine composition and its prepn |
| 06/06/2007 | CN1973886A Gastropathy treating Chinese medicine composition and its prepn form and prepn process |
| 06/06/2007 | CN1973885A Shenjing capsule and shenjing oral liquid |
| 06/06/2007 | CN1973884A Bobei throat-fitting buccal tablet |